Please provide your email address to receive an email when new articles are posted on . Robin R. Chamberland, PhD, of the Saint Louis University School of Medicine, and colleagues studied 172 randomly ...

Norovirus leading offender in pediatric gastroenteritis Norovirus far exceeds rotavirus as the leading cause of medically attended acute gastroenteritis in U.S. children. HealthDay News — Norovirus ...

Acute gastroenteritis (AGE) in the pediatric population remains a significant cause of pediatric patient morbidity and mortality. For these patients, oral rehydration therapy is an intervention that ...

Please provide your email address to receive an email when new articles are posted on . Postdischarge ondansetron reduced vomiting and disease severity among children with acute gastroenteritis.

Researchers found that moderate-to-severe gastroenteritis occurred in 5.1% of 452 participants in the ondansetron group and in 12.5% of 441 participants in the placebo group. HealthDay News — For ...

Treatment with ondansetron for pediatric gastrointestinal illnesses was associated with decreased rates of return to the emergency department or urgent care within 72 hours. For pediatric patients ...

Researchers have demonstrated that a drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis. University of North ...

New research being presented at the American Academy of Pediatrics 2019 National Conference & Exhibition suggests that the treatment children receive in U.S. emergency departments for acute ...

Most children seeking emergency department (ED) care due to vomiting are discharged home. Although they usually feel better when they leave the ED, the vomiting recurs in nearly one-third of children.

Pediatric gastroenteritis places a considerable disease burden on children of the developed world. The national surveillance of gastroenteritis in Ireland is a combined virological and epidemiologic ...

These recent studies reveal the potential benefits of ondansetron, when administered as both oral and iv. agents, to children with AGE complicated by vomiting. Studies have focused on the impact of ...